JIGAR GEPATOSELLYULYAR KARSINOMASINI DIAGNOSTIKASIDA MAGNIT-REZONANS TOMOGRAFIYASINING ROLI
Keywords:
Gepatosellyulyar karsinoma, jigar, magnit-rezonans tomografiya, MRT, diagnostika, diffuziya-vaznlangan tasvirlash, kontrastlash, onkologiya.Abstract
Mazkur maqolada jigar gepatosellyulyar karsinomasini diagnostika qilishda magnit-rezonans tomografiyaning (MRT) o‘rni tahlil qilindi.
Gepatosellyulyar karsinoma jigar o‘smalarining eng ko‘p uchraydigan birlamchi malign shakllaridan biri bo‘lib, uni erta aniqlash kasallik prognozini yaxshilashda muhim ahamiyatga ega. Tadqiqotda MRTning kontrast kuchaytiruvchi usullari, diffuziya-vaznlangan tasvirlash va dinamik kontrastlash imkoniyatlari ko‘rib chiqildi. Shuningdek, MRTning kompyuter tomografiyasi va ultratovush tekshiruviga nisbatan
afzalliklari yoritildi. Olingan natijalar MRT jigar gepatosellyulyar karsinomasini erta diagnostika qilishda yuqori sezuvchanlik va aniqlikka ega ekanligini ko‘rsatdi.
References
1. World Health Organization. Global Cancer Observatory Report. Geneva:
WHO; 2023.
2. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global
Cancer Statistics 2021 // CA: A Cancer Journal for Clinicians. 2021;71(3):209–
249.
3. El-Serag H.B. Hepatocellular Carcinoma // New England Journal of Medicine.
2020;382(11):1074–1084.
4. Forner A., Reig M., Bruix J. Hepatocellular Carcinoma // Lancet.
2022;399(10327):1345–1362.
5. European Association for the Study of the Liver (EASL). Clinical Practice
Guidelines: Management of Hepatocellular Carcinoma. 2023.
6. Mitchell D.G., Bruix J., Sherman M. MRI of the Liver and Hepatocellular
Carcinoma // Radiology. 2021;299(2):320–336.
7. Kim Y.K., Park B.J., Kim C.S. Dynamic Contrast-Enhanced MRI in
Hepatocellular Carcinoma // American Journal of Roentgenology.
2020;214(5):1120–1130.
8. Taouli B., Koh D.M. Diffusion-Weighted Imaging Outside the Brain:
Applications in Oncology // Radiographics. 2021;41(1):45–62.
9. Lee J.M., Yoon J.H., Joo I. Diagnostic Accuracy of MRI for Small
Hepatocellular Carcinoma // Journal of Hepatology. 2022;76(4):879–890.
10.Kono Y., Lyshchik A., Cosgrove D. Diffusion Restriction in Hepatic
Malignancies // Abdominal Radiology. 2021;46(8):3780–3792.
11.American College of Radiology. LI-RADS v2023 Core Manual. Reston, VA;
2023.
12.Chernyak V., Fowler K.J., Kamaya A. Liver Imaging Reporting and Data
System (LI-RADS) // Radiologic Clinics of North America. 2022;60(4):651–
669.
13.Marrero J.A., Kulik L.M., Sirlin C.B. Diagnosis, Staging and Management of
Hepatocellular Carcinoma // Hepatology. 2021;74(1):364–395.
14.Choi S.H., Byun J.H., Lim Y.S. Role of Diffusion-Weighted Imaging in Liver
Oncology // Clinical Imaging. 2020;65:58–67.
15.Ronot M., Vilgrain V. MRI Evaluation of Focal Liver Lesions // Diagnostic
and Interventional Imaging. 2021;102(9):509–521.
16.An C., Kim D.W., Park Y.N. Hypervascular Liver Tumors on MRI // European
Radiology. 2022;32(7):4381–4392.
17.Semelka R.C., Armao D.M., Elias J. MRI Safety and Clinical Applications //
Magnetic Resonance Imaging Clinics. 2021;29(2):181–194.
18.Grazioli L., Bondioni M.P., Haradome H. Contrast Agents in Liver MRI //
Insights into Imaging. 2020;11(1):96–108.
19.Villanueva A. Hepatocellular Carcinoma Pathogenesis and Molecular Biology
// Nature Reviews Gastroenterology & Hepatology. 2022;19(2):63–80.
20.Sherman M. Hepatocellular Carcinoma Surveillance and Early Diagnosis //
Hepatology. 2021;74(4):2380–2392.
21.Roberts L.R., Sirlin C.B., Zaiem F. Imaging for the Diagnosis of
Hepatocellular Carcinoma // Gastroenterology. 2023;164(1):55–70.
22.Kim T.K., Jang H.J. Imaging Techniques for Liver Cancer Evaluation //
Ultrasound Quarterly. 2021;37(3):191–202.
23.Bosch F.X., Ribes J., Díaz M. Primary Liver Cancer Worldwide Incidence and
Trends // Gastroenterology. 2020;159(3):913–923.
24.Omata M., Cheng A.L., Kokudo N. Asia-Pacific Clinical Practice Guidelines
on the Management of Hepatocellular Carcinoma // Hepatology International.
2022;16(2):223–278.
25.Llovet J.M., Kelley R.K., Villanueva A. Advances in Hepatocellular
Carcinoma Research and Treatment // Nature Reviews Clinical Oncology.
2023;20(10):599–614.